-Atossa Therapeutics Inc (ATOS) stock is trading at $4.76 as of 10:00 AM on Friday, Jun 4, a rise of $0.32, or 7.09% from the previous closing price of $4.44. The stock has traded between $4.55 and $4.92 so far today. Volume today is light. So far 2,739,675 shares have traded compared to average volume of 13,614,422 shares.
-Atossa Therapeutics Inc is a...
NASDAQ:ATOS
This is the last chance, before market close buy whatever you can, price targets are 7$, 12$, 20$ if short squeeze happen, then over 100$
This is my idea and could be wrong 100%
TARGET HIT @ 4.09 for 29.43 Profit in 118 days
Woooooot... long time for 30% but it's a win...
And if you took this trade from my second notification you might even be up 140%...
Good Game... I like this one quite a bit...
Stop loss: 2.40
Hard Stop loss: 2.1
Profit taking: 3.57, 4.23 - 4.86(Strong resistance area)
If 4.86 price get's broken we might see a high target of 8$ for now.
Would be looking to buy day 2 low of day looking for it to hold the prev day high
Exit - Selling open day 3 looking for a 10-15% bounce
Pattern 2 - Buy day 2 low hold overnight
Atossa Therapeutics Inc (NASDAQ:ATOS) had a great move on the upside yesterday and closed above the 2.75 resistance area. The stock is setting up to break out and has one more level to go, which is $3.08. Long setup on watch.
$ATOS Target 4.09 for 29.43%
Or next add level is at 2.23
Support at the MA of RSI... let's go towards target 🙌🏼
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am...
The chart has a high potential to bounce of at this VPOC and head upwards to 2,7 USD. Is this will happen with high volume it will stay for a while and then go upwards. Yesterday there was institutional buying. It is going down because they want it cheap and it lakcks volume.
Will the Top at 2.65 USD be tested or will it go down to 2,0 USD (Volume Point of Control) first?
The most analysts aim for 7.5 USD for end of this year. With the cancer therapies in their portfolio it will be there a lot earlier I think.
Pivoting off Support and up-trending towards Resistance, time sequence within Wave analysis
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to...
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for...
